Locately, MoFuse, Care.com, & More Names from the Boston Deals Roundup

8/22/12Follow @xconomy

Health IT, mobile, database, and biofuel tech companies in New England have been making deals this week.

—Locately, the Boston-based mobile location analytics startup, was bought by the Service Management Group, a Kansas City, MO-based market research firm, for an undisclosed cash sum.

—Sqrrl, a Washington, DC-founded maker of secure database software, nabbed $2 million in funding and is setting up shop in Boston, the Boston Globe first reported. The money comes from Matrix Partners and Atlas Venture, and is new partner Chris Lynch’s first investment with Atlas. Sqrrl CEO Oren Falkowitz says the now seven-person company will use the funds to staff up in Kendall Square, and  to “recruit the top engineering talent to develop the product and deliver it to customers.”

—Boston-based Best Doctors nabbed $45.5 million in a round of funding from Brown Brothers Harriman & Co., VentureWire reported. The startup, which maintains a 50,000-doctor database that can be used for second opinions on diagnoses and treatment plans for patients, has previously raised $20 million from Munich Re Group, Coleman Swenson Booth, Polaris Venture Partners, Psilos Group Managers, Southeastern Technology Fund, and Toronto Dominion Partners.

—Slater Technology Fund announced that it backed MoFuse, a Warwick, RI-based mobile content management startup, in a new $525,000 round of funding that included Beacon Angels, Angel Street Capital, and Cherrystone Angel Group. Slater, an investment fund backed by the state of Rhode Island, has put a total of $580,000 into MoFuse.

—Waltham, MA-based Care.com made good on its promise to put its $50 million in new funding toward acquisitions: the company announced that it has picked up Breedlove & Associates, an Austin, TX-based provider of household payroll, tax, and compliance services.

—Agrivida, a Medford, MA-based company engineering plants for biofuel production, inked a deal to sell its feedstock and processing technology to a subsidiary of the ethanol developer POET.

By posting a comment, you agree to our terms and conditions.